Randox at MEDLAB Middle East 2017 - Stand No. Z5.B10

Location : Dubai International Convention & Exhibition Centre
  Date : 5th - 8th of February 2018

Dedicated to Improving Health Worldwide

Randox Laboratories will be attending MEDLAB Middle East from the 4th – 7th of February 2019.
Our innovative diagnostic solutions have been developed with consolidation and economy in mind, providing cost savings whilst using pioneering technology.

Diagnostics is our passion. We are dedicated to developing solutions that not only meet your needs, but that are of the highest quality,
the most reliable and the most cost-effective. We look forward to meeting you in the World Trade Centre Dubai, at our Stand No. Z5.B10

 View Our New Products

What can we offer?

RX series

The RX series of clinical chemistry analysers provides robust hardware combined with intuitive software ensuring unrivalled precision and accuracy for results you can trust.


Committed to advancing biochemistry testing for laboratories. We offer a range of high quality reagents that cover routine and novel markers with applications for use on a wide range of clinical chemistry analysers.

Quality Control

Delivering accurate results, Randox QC provides the complete laboratory package combining true third party controls, calibration verification material, interlaboratory data management software and the world’s largest international EQA scheme – RIQAS.


Dedicated to advancing scientific discovery, drug development and diagnostics spanning four key divisions; Life Sciences, Pharma Sciences, Research and Molecular;

Evidence Series

The Evidence series of immunoassay analysers have been developed using patented Biochip Array Technology. Developed by Randox Laboratories in 2002, highly innovative Biochip Array Technology (BAT) instantly changed the landscape of diagnostic testing forever.


Randox Toxicology offer the most comprehensive Drugs of Abuse test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to ever changing drug market.